| ONCS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ONCS shares outstanding history going back to 5/18/2015:
Also see: ONCS Market Cap History ONCS YTD Return |
As of 12/15/2022 OncoSec Medical has 2.97 million ONCS shares outstanding. Investors often track the ONCS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ONCS share count trends over time, with 38 historical shares outstanding datapoints presented, dating back to 5/18/2015.

| ONCS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ONCS shares outstanding history going back to 5/18/2015:
Also see: ONCS Market Cap History ONCS YTD Return |
| ONCS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ONCS Historical Shares Outstanding: +68.76% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ONCS Stock Price Chart |
| About OncoSec Medical Inc |
| OncoSec Medical is a late-stage immuno-oncology company focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Co.'s main technology, ImmunoPulse®, is a drug-device therapeutic modality platform comprised of OncoSec Medical System EP device (the OMS EP Device) and a DNA plasmid delivery and application method. The OMS EP Device can be adapted to treat various tumor types, and consists of an electrical pulse generator and disposable applicator. Co.'s main product candidate is a plasmid encoding interleukin-12 called tavokinogene telseplasmid. We show 38 historical shares outstanding datapoints in our coverage of ONCS's shares outstanding history. Understanding the changing numbers of ONCS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ONCS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ONCS by allowing them to research ONCS shares outstanding history as well as any other stock in our coverage universe. |
| ONCS Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| ONCS Share Performance |
| Shares Outstanding Peers |
| OncoSec Medical (ONCS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ONCT Shares Outstanding History ONCY Shares Outstanding History ONEM Shares Outstanding History ONS Shares Outstanding History ONTX Shares Outstanding History ONVO Shares Outstanding History OPCH Shares Outstanding History OPGN Shares Outstanding History OPHT Shares Outstanding History OPK Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.